The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
基本信息
- 批准号:10715568
- 负责人:
- 金额:$ 285.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:AcademyAddressAdultAmericanAreaAwardClinicalClinical InvestigatorClinical ResearchClinical SciencesClinical SkillsClinical TrialsClinical and Translational Science AwardsCohort StudiesCollaborationsCommunicationConduct Clinical TrialsDataDatabasesDecision MakingDevelopmentEligibility DeterminationEnrollmentEnsureExpenditureFundingGoalsHuman ResourcesIndividualIndustryInstitutionJournalsLeadershipLong COVIDMarketingMentorshipMethodsMinority GroupsMinority ParticipationMonitorNational Institute of General Medical SciencesObservational StudyParticipantPatient RecruitmentsPharmacistsPhasePrincipal InvestigatorProgram DevelopmentProgram EvaluationPuerto RicoResearchResearch PersonnelResourcesRural PopulationSeriesServicesSiteStructureTimeTrainingTranslational ResearchUnderrepresented MinorityUnderserved PopulationUnited StatesUnited States National Institutes of HealthWest Virginiaclinical centerclinical trial participantclinically relevanteligible participantexperienceinstitutional capacityinterestobservational cohort studyonline deliverypatient populationprogramsrepositoryrural Americarural Americansskillssuccessweb site
项目摘要
There are currently nearly 8,000 clinical trials and observational cohort studies funded by the National Institutes
of Health in the United States, yet less than 10% of these studies are conducted in Institutional Development
Award (IDeA) states that serve underrepresented minority and rural populations. Not surprisingly, only
approximately 7% of expenditures for clinical trials and observational studies go to the 23 IDeA states and Puerto
Rico. Barriers that limit expansion of clinical trial and cohort studies in IDeA states include lack of effective
communication to trial sponsors of the expertise and capability that IDeA institutions possess to effectively
conduct clinical studies, effective communication to IDeA investigators regarding clinical trials opportunities, and
lack of clinical trial coordinators. The overall goal of this project is to increase numbers of clinical trials and
observational cohort studies in IDeA states, thereby increasing trial availability and participation of minority and
rural populations historically underrepresented in clinical trials. We will achieve this goal by establishing the IDeA
State Consortium for Clinical Research Resource Center (ISCORE-RC) comprised of the Clinical Trials Service
Center and the Clinical Research Coordinator (CRC) Development Program to address the identified barriers
through accomplishment of the following specific aims. Aim 1 - Effectively communicate and market to
clinical trial sponsors the expertise, quality, and capacity of IDeA state institutions to conduct clinical
trials. We will accomplish this aim through several tactics to include leveraging the TriNetX platform that
connects clinical trial sponsors with institutions serving relevant patient populations to identify sites with
potentially eligible participants for specific clinical trials, creating a repository containing site-specific profiles
showcasing strengths of individual IDeA state trial groups, establishing an ISCORE-RC website that provides a
public resource to demonstrate benefits of partnering with IDeA organizations to increase clinical trial participant
representation from underserved populations, and facilitating networking of sponsors with investigators. Aim 2 -
Communicate to IDeA state investigators clinical trial opportunities. To accomplish this goal, we will
develop site specific search criteria in clinicaltrials.gov that will allow the ISCORE-RC Clinical Trials Service Core
to monitor relevant clinical trials of interest currently in the participant recruitment phase. Aim 3 - Train a cadre
of skilled clinical research coordinators. Entry into this program will be open to experienced clinical personnel
as well as to non-clinical individuals. Both part-time and full-time effort of trainees will be accommodated. The
program will include an online didactic portion, journal club, and seminar series as well as a prominent
experiential component to be conducted at participating sites. Upon completion of the core content, participants
will receive a CRC basic training certificate and will be eligible for further training towards an advanced training
certificate and membership in the ISCORE-RC CRC Academy, a networking and professional development
platform that includes current research coordinators at participating sites as well as trainees.
目前有近8,000项临床试验和观察性队列研究由美国国立研究院资助
在美国的健康,但不到10%的这些研究是在机构发展进行的
奖(IDEA)规定,服务于代表性不足的少数民族和农村人口。毫不奇怪,只有
大约7%的临床试验和观察性研究支出用于23个州和波多黎各
瑞可限制IDEA州临床试验和队列研究扩展的障碍包括缺乏有效的
与试验申办者沟通IDEA机构拥有的专业知识和能力,
开展临床研究,就临床试验机会与IDEA研究者进行有效沟通,以及
缺乏临床试验协调员。该项目的总体目标是增加临床试验的数量,
IDEA州的观察性队列研究,从而增加试验的可用性和少数族裔和少数族裔的参与
农村人口在临床试验中的代表性历来不足。我们将通过建立IDEA来实现这一目标
由临床试验服务部门组成的国家临床研究资源中心联盟(ISCORE-RC)
中心和临床研究协调员(CRC)开发计划,以解决已识别的障碍
通过实现以下具体目标。目标1 -有效沟通和营销
临床试验赞助商的专业知识,质量和能力的IDEA国家机构进行临床
审判我们将通过多种策略实现这一目标,包括利用TriNetX平台,
将临床试验申办者与服务于相关患者人群的机构联系起来,以确定具有
特定临床试验的潜在合格参与者,创建包含特定研究中心配置文件的存储库
展示各个IDEA州试验组的优势,建立一个ISCORE-RC网站,
展示与IDEA组织合作以增加临床试验参与者的益处的公共资源
代表性不足的人口,并促进赞助商与调查人员的网络。目标2 -
与IDEA州研究者沟通临床试验机会。为了实现这一目标,我们将
在clinicaltrials.gov中制定研究中心特定的搜索标准,以允许ISCORE-RC临床试验服务核心
监测目前处于参与者招募阶段的相关临床试验。目标3 -培养干部
熟练的临床研究协调员。进入这个程序将开放给有经验的临床人员
以及非临床个体。学员的兼职和全职工作都将得到照顾。的
该计划将包括一个在线教学部分,期刊俱乐部,和研讨会系列,以及一个突出的
将在参与地点进行体验部分。完成核心内容后,参与者
将获得CRC基础培训证书,并有资格接受进一步培训,以进行高级培训
证书和ISCORE-RC CRC学院的成员资格,这是一个网络和专业发展
该平台包括参与研究中心的现有研究协调员以及受训人员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sally Lynn Hodder其他文献
Sally Lynn Hodder的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sally Lynn Hodder', 18)}}的其他基金
West Virginia Clinical and Translational Science Institute: Improving Health through Partnerships and Transformative Research
西弗吉尼亚临床和转化科学研究所:通过合作伙伴关系和变革性研究改善健康
- 批准号:
10435710 - 财政年份:2021
- 资助金额:
$ 285.9万 - 项目类别:
West Virginia Clinical and Translational Science Institute: A Statewide Organization Building Research Excellence and Engaging Communities to Improve Health
西弗吉尼亚州临床和转化科学研究所:全州范围内的组织,致力于打造卓越研究并吸引社区改善健康
- 批准号:
10685808 - 财政年份:2012
- 资助金额:
$ 285.9万 - 项目类别:
West Virginia Clinical and Translational Science Institute: A Statewide Organization Building Research Excellence and Engaging Communities to Improve Health
西弗吉尼亚州临床和转化科学研究所:全州范围内的组织,致力于打造卓越研究并吸引社区改善健康
- 批准号:
10876541 - 财政年份:2012
- 资助金额:
$ 285.9万 - 项目类别:
West Virginia Clinical and Translational Science Institute: Improving Health through Partnerships and Transformative Research
西弗吉尼亚临床和转化科学研究所:通过合作伙伴关系和变革性研究改善健康
- 批准号:
10213751 - 财政年份:2012
- 资助金额:
$ 285.9万 - 项目类别:
West Virginia Clinical and Translational Science Institute: A Statewide Organization Building Research Excellence and Engaging Communities to Improve Health
西弗吉尼亚州临床和转化科学研究所:全州范围内的组织,致力于打造卓越研究并吸引社区改善健康
- 批准号:
10842070 - 财政年份:2012
- 资助金额:
$ 285.9万 - 项目类别:
West Virginia Clinical and Translational Science Institute: Improving Health through Partnerships and Transformative Research
西弗吉尼亚临床和转化科学研究所:通过合作伙伴关系和变革性研究改善健康
- 批准号:
10293104 - 财政年份:2012
- 资助金额:
$ 285.9万 - 项目类别:
Alterations and Renovations for Clinical Research Resources and Facilities
临床研究资源和设施的改造和翻新
- 批准号:
10505672 - 财政年份:2012
- 资助金额:
$ 285.9万 - 项目类别:
Driving Cutting Edge Clinical Trial Enrollment in Rural Populations: West Virginia's Mobile Clinical Trials Unit
推动农村人口的尖端临床试验注册:西弗吉尼亚州的移动临床试验单位
- 批准号:
10400301 - 财政年份:2012
- 资助金额:
$ 285.9万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 285.9万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 285.9万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 285.9万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 285.9万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 285.9万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 285.9万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 285.9万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 285.9万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 285.9万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 285.9万 - 项目类别:
Research Grant